The American Academy of Neurology (AAN) has issued a position statement on therapies for neurological conditions that have ...

As new treatments emerge, timely diagnosis helps match patients with the most appropriate care when it can have the greatest ...

The FDA cleared an artificial intelligence (AI)-powered wristband (Felix NeuroAI) to treat upper-limb functional limitations ...

An autopsy study of a 45-year-old former U.S. Navy crewman with severe chronic traumatic encephalopathy (CTE) suggested that ...

What makes this tool innovative is its ability to detect subtle brain activity patterns often invisible to the human eye and ...

Some 25 years ago, a young Parkinson's disease investigator, Robert Hauser, MD, stepped to the podium at an American Academy ...

The American Academy of Neurology issues new guidelines to help clinicians navigate the use of unproven neurologic therapies lacking FDA approval or strong evidence.

The annual meeting of the American Academy of Neurology (AAN) allows neurology experts from around the globe to share their latest clinical insights and expertise in patient care.

People living in more disadvantaged neighborhoods may be more likely to have biomarkers for inflammation and Alzheimer's ...

University of Minnesota spinout Fasikl has obtained an FDA clearance for its artificial-intelligence-powered wearable for ...

The FDA has approved the Felix NeuroAI Wristband, a wearable AI-driven neurostimulation device, for treating upper limb ...